Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Seong Kyun Na, Byung-Cheol Song
Clin Mol Hepatol. 2019;25(3):234-244.   Published online 2019 Jan 21     DOI: https://doi.org/10.3350/cmh.2018.0108
Citations to this article as recorded by Crossref logo
A scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis
Kyunghan Lee, Gwang Hyeon Choi, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim
Scientific Reports.2022;[Epub]     CrossRef
Liver CT Perfusion Imaging as a Non-Invasive Method for Assessing Hemodynamics of the Hepatic Parenchyma in Patients with Fibrosis and Cirrhosis as a Result of Chronic Viral Hepatitis C
G. A. Stashuk, Ya. G. Moysyuk, D. Ya. Smirnova, O. V. Sumtsova
Journal of radiology and nuclear medicine.2022; 102(6): 359.     CrossRef
Treatment-Resistant Hepatitis C Viral Infection: A Case Report and Literature Review
Victoria Green, Marina Roytman, Haruki Komatsu
Case Reports in Hepatology.2022; 2022: 1.     CrossRef
Hepatocellular Carcinoma-Related Mortality in the USA, 1999–2018
Azaan Ramani, Elliot B. Tapper, Connor Griffin, Nagasri Shankar, Neehar D. Parikh, Sumeet K. Asrani
Digestive Diseases and Sciences.2022; 67(8): 4100.     CrossRef
Risk of hepatocellular carcinoma in patients with chronic hepatitis c infection and stage 3 fibrosis after sustained virological response
Antonio Olveira Martín, María Luisa García Montes, María Sanchez-Azofra
Revista Española de Enfermedades Digestivas.2022;[Epub]     CrossRef
Hepatocellular carcinoma incidence in chronic hepatitis C patients according to sustained virological response ( SVR ) with interferon‐based therapies and baseline characteristics
Tuul Purevsambuu, Simona Bota, Florian Hucke, Harald Hofer, Peter Ferenci, Wolfgang Sieghart, Markus Peck‐Radosavljevic
Liver Cancer International.2022; 3(2): 53.     CrossRef
Lifestyles Associated with Prognosis After Eradication of Hepatitis C Virus: A Prospective Cohort Study in Japan
Satoko Ohfuji, Tomoka Matsuura, Akihiro Tamori, Shoji Kubo, Satoshi Sasaki, Kyoko Kondo, Kazuya Ito, Wakaba Fukushima
Digestive Diseases and Sciences.2021; 66(6): 2118.     CrossRef
N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition
Geon-Woo Kim, Aleem Siddiqui
Proceedings of the National Academy of Sciences.2021;[Epub]     CrossRef
Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C
Hala Rady Ahmed, Nancy G. F. M. Waly, Rehab Mahmoud Abd El-Baky, Ramadan Yahia, Helal F. Hetta, Amr M. Elsayed, Reham Ali Ibrahem, Philippe Gallay
PLOS ONE.2021; 16(4): e0249770.     CrossRef
Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea
Jae Seung Lee, Hong Jun Choi, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2021; 36(9): 2479.     CrossRef
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
Present and future management of viral hepatitis
Rocío González Grande, Inmaculada Santaella Leiva, Susana López Ortega, Miguel Jiménez Pérez
World Journal of Gastroenterology.2021; 27(47): 8081.     CrossRef
Hepatitis C Virus Translation Regulation
Michael Niepmann, Gesche K. Gerresheim
International Journal of Molecular Sciences.2020; 21(7): 2328.     CrossRef
A Survey of Liver Cancer Specialists’ Views on the National Liver Cancer Screening Program in Korea
Won Sohn, Young-Sun Lee, Jae Geun Lee, Jihyun An, Eun Sun Jang, Dong Ho Lee, Dong Hyun Sinn
Journal of Liver Cancer.2020; 20(1): 53.     CrossRef
Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C
Kazuhide Takata, Fuminori Ishii, Yotaro Uchida, Hiromi Fukuda, Ryo Yamauchi, Kaoru Umeda, Naoaki Tsuchiya, Takashi Tanaka, Keiji Yokoyama, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai
Internal Medicine.2020; 59(15): 1855.     CrossRef
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung-Feng Huang, Ming-Lung Yu
Clinical and Molecular Hepatology.2020; 26(3): 251.     CrossRef
The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands
Mohamed N.M.T. Al Khayat, Job F.H. Eijsink, Maarten J. Postma, Jan C. Wilschut, Marinus van Hulst
International Journal of Environmental Research and Public Health.2020; 17(17): 6091.     CrossRef
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(11): 3414.     CrossRef
Immune Checkpoint Inhibition is Safe and Effective for Liver Cancer Prevention in a Mouse Model of Hepatocellular Carcinoma
Andrew S. Chung, Marcel Mettlen, Debolina Ganguly, Tianshi Lu, Tao Wang, Rolf A. Brekken, David Hsiehchen, Hao Zhu
Cancer Prevention Research.2020; 13(11): 911.     CrossRef
Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells
Gerresheim, Roeb, Michel, Niepmann
Cells.2019; 8(11): 1410.     CrossRef